APA   Click to copy
Arruda, E. A. G., Pires-Neto, R. J., Medeiros, M. S., Quirino-Filho, J., Clementino, M., Gondim, R. N. D. G., … others. (2021). Clinical Features, Pathobiology, Efficacy, and Toxicity of Tenofovir Disoproxil Fumarate and Emtricitabine for Mild to Moderate SARS-CoV-2 Infections. European Journal of Respiratory Medicine, 3, 238–248.

Chicago/Turabian   Click to copy
Arruda, EAG, RJ Pires-Neto, MS Medeiros, J Quirino-Filho, M Clementino, RNDG Gondim, LMVC Magalh{\~a}es, et al. “Clinical Features, Pathobiology, Efficacy, and Toxicity of Tenofovir Disoproxil Fumarate and Emtricitabine for Mild to Moderate SARS-CoV-2 Infections.” European Journal of Respiratory Medicine 3 (2021): 238–248.

MLA   Click to copy
Arruda, E. AG, et al. “Clinical Features, Pathobiology, Efficacy, and Toxicity of Tenofovir Disoproxil Fumarate and Emtricitabine for Mild to Moderate SARS-CoV-2 Infections.” European Journal of Respiratory Medicine, vol. 3, 2021, pp. 238–48.

@article{arruda2021a,
  title = {Clinical Features, Pathobiology, Efficacy, and Toxicity of Tenofovir Disoproxil Fumarate and Emtricitabine for Mild to Moderate SARS-CoV-2 Infections},
  year = {2021},
  journal = {European Journal of Respiratory Medicine},
  pages = {238--248},
  volume = {3},
  author = {Arruda, EAG and Pires-Neto, RJ and Medeiros, MS and Quirino-Filho, J and Clementino, M and Gondim, RNDG and Magalh{\~a}es, LMVC and Cavalcante, KF and Viana, VAF and Mello, LP and others}
}